PV Bulletin

Category

AI/GxP

Latest pharmacovigilance updates in AI/GxP.

publicFda · United Kingdom · Updated May 24, 2026

MHRA updates SaMD/AIaMD guidance, highlighting PCCP and transparency principles

Urgency: High

Ask the safety/device vigilance and PV CSV leads to: (1) confirm whether any marketed/fielded SaMD/AIaMD uses adaptive ML or planned updates that would fit a PCCP-like approach; (2) review current change-control SOPs and technical documentation to ensure change governance and transparency artifacts are captured and retrievable; (3) verify post-market/vigilance processes explicitly account for algorithm updates (e.g., monitoring after updates, escalation criteria).

Risk ManagementDevice VigilanceSignal Management Lead
SOP Impact5 SOPs
ConfidenceMedium
Relevant for: Signal Management Lead, Regulatory Intelligence Lead, Medical Device Vigilance Lead
verifiedRegulatory action: AI/GxP
Read impact briefarrow_forward
publicEma · Updated May 22, 2026

MHRA reiterates GxP data integrity spans GVP as Annex 11 evolves

Urgency: High

Ema update requires triage for Local Affiliate Compliance, Vendor Oversight, Inspection Readiness; confirm local obligations and document follow-up actions.

Local Affiliate ComplianceVendor OversightQPPV
SOP Impact7 SOPs
ConfidenceMedium
Relevant for: QPPV, Local Safety Officer, Signal Management Lead
verifiedRegulatory action: AI/GxP
Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: Signal Management Lead. Work email only